Autonomic nervous system dysfunction, common in patients with Parkinson’s disease (PD), causes significant morbidity and it is correlated with poor quality of life. To assess frequency of urinary symptoms in patients with PD, without conditions known to interfere with urinary function.
Non-demented PD patients were consecutively enrolled from the outpatients clinic of our department. Scales investigating motor and non-motor symptoms were carried out. Evaluation of urinary dysfunctions was carried out using the AUTonomic Scale for Outcomes in Parkinson’s disease (SCOPA-AUT) questionnaire. Patients underwent noninvasive urological studies (nUS), including uroflowmetry and ultrasound of the urinary tract.
Forty-eight (20 women, 42%) out of 187 PD patients met the inclusion criteria and were enrolled in the study. Mean SCOPA-AUT score was 14.1 ± 6.9 (urinary symptoms subscore 5.2 ± 3.8). Among those evaluated by the SCOPA-AUT scale, the urinary symptoms were among the most common complaints (93.8%). At nUS mean maximum flow rate (Qmax) was 17.9 ± 9.1 ml/s, and mean postvoid residual (PVR) urine volume was 24.4 ± 44.1 ml. Ultrasound investigation documented prostate hypertrophy in 12 male patients (42.8%). Urinary items of the SCOPA-AUT (SCOPA-U subscore) correlated with measures of disease severity only in female patients.
Urinary symptoms and abnormal findings in nUS are common in PD. Though nigrostriatal degeneration might be responsible for urinary symptoms also in the early-intermediate stage of the disease, when urinary dysfunction occurs other medical conditions need to be excluded.
Jost WH. Autonomic dysfunctions in idiopathic Parkinson’s disease. J Neurol. 2003;250(Suppl. 1):I28–30. CrossRef
Picillo M, Palladino R, Barone P, Erro R, Colosimo C, Marconi R, Morgante L, Antonini A, on behalf of the PRIAMO Study Group. The PRIAMO study: urinary dysfunction as a marker of disease progression in early Parkinson’s disease. Eur J Neurol. 2017;24:788–95. https://doi.org/10.1111/ene.13290. CrossRefPubMed
Winge K. Lower urinary tract dysfunction in patients with parkinsonism and other neurodegenerative disorders. Handb Clin Neurol. 2015;130:335–56. https://doi.org/10.1016/B978-0-444-63247-0.00019-5. CrossRefPubMed
Barone P, Antonini A, Colosimo C, Marconi R, Morgante L, Avarello TP, Bottacchi E, Cannas A, Ceravolo G, Ceravolo R, Cicarelli G, Gaglio RM, Giglia RM, Iemolo F, Manfredi M, Meco G, Nicoletti A, Pederzoli M, Petrone A, Pisani A, Pontieri FE, Quatrale R, Ramat S, Scala R, Volpe G, Zappulla S, Bentivoglio AR, Stocchi F, Trianni G, Dotto PD, PRIAMO study group. The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease. Mov Disord. 2009;24:1641–9. https://doi.org/10.1002/mds.22643. CrossRefPubMed
Visser M, Marinus J, Stiggelbout AM, van Hilten JJ. Assessment of autonomic dysfunction in Parkinson’s disease: the SCOPA-AUT. Mov Disord. 2004;19:1306–12. CrossRef
Uchiyama T, Sakakibara R, Yamamoto T, Ito T, Yamaguchi C, Awa Y, Yanagisawa M, Higuchi Y, Sato Y, Ichikawa T, Yamanishi T, Hattori T, Kuwabara S. Urinary dysfunction in early and untreated Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2011;82:1382–6. https://doi.org/10.1136/jnnp.2011.241075. CrossRefPubMed
Chaudhuri KR, Martinez-Martin P, Brown RG. The metric properties of a novel non-motor symptoms scale for Parkinson’s disease: reults from a international pilot study (2007) Mov. Disorders. 22:1901–11. CrossRef
Violante MR, Zeron-Martınez R, Arriaga A, Corona T. Who can diagnose Parkinson’s disease first? Role of pre-motor symptoms. Arch Med Res. 2017;48:221–7. https://doi.org/10.1016/j.arcmed.2017.08.005. CrossRef
Erro R, Picillo M, Amboni M, Moccia M, Vitale C, Longo K, Pellecchia MT, Santangelo G, Martinez-Martin P, Chaudhuri KR, Barone P. Nonmotor predictors for levodopa requirement in De novo patients with Parkinson’s disease. Mov Disord. 2015;30:373–8. https://doi.org/10.1002/mds.26076. CrossRefPubMed
Chaudhuri KR, Schapira AH. Non-motor symptoms of Parkinson’s disease: dopaminergic pathophysiology and treatment. Lancet Neurol. 2009;8:464–74. https://doi.org/10.1016/S1474-4422(09)70068-7. CrossRefPubMed
Arnao V, Cinturino A, Valentino F, Perini V, Mastrilli S, Bellavia G, Savettieri G, Realmuto S, D’Amelio M. In patients with Parkinson disease, autonomic symptoms are frequent and associated with other non-motor symptoms. Clin Auton Res. 2015;(5):301–7. https://doi.org/10.1007/s10286-015-0306-x. CrossRef
Braak H, Del Tredici K, Rüb U, de Vos RAI, Jansen Steur ENH, Braak E. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging. 2003;24:197–210.
Campos-Sousa RN, Quagliato E, Silva BBd, Jr de Carvalho RM, Ribeiro SC, de Carvalho DF. Urinary symptoms in Parkinson‘disease: prevalence and associated factors. Arq Neuropsiquiatr. 2003;61:359–63. CrossRef
- Urological dysfunctions in patients with Parkinson’s disease: clues from clinical and non-invasive urological assessment
Tommaso Vincenzo Bartolotta
- BioMed Central